Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

SARS-CoV-2 variants are evolving new ways to evade antibodies and vaccines

SARS-CoV-2 variants are evolving new ways to evade antibodies and vaccines

For most young people, COVID vaccine-related myocarditis is not serious

For most young people, COVID vaccine-related myocarditis is not serious

Neutralization antibodies elevated in nursing home residents after COVID-19 mRNA boosters

Neutralization antibodies elevated in nursing home residents after COVID-19 mRNA boosters

Internal tremors and vibrations symptoms among people with long-COVID

Internal tremors and vibrations symptoms among people with long-COVID

AlphaFold AI predicts SARS-CoV-2 omicron variant might not evade antibody neutralization

AlphaFold AI predicts SARS-CoV-2 omicron variant might not evade antibody neutralization

Characterization of the baseline SARS-CoV-2 S-reactive B cell repertoire

Characterization of the baseline SARS-CoV-2 S-reactive B cell repertoire

Study identifies ORF8 protein as a key COVID-19 causing factor

Study identifies ORF8 protein as a key COVID-19 causing factor

SARS-CoV-2 antibody profiles in vaccinated and convalescent macaques compared to humans

SARS-CoV-2 antibody profiles in vaccinated and convalescent macaques compared to humans

Equilibrium simulation of SARS-CoV-2 spike protein highlights its global conformational characteristics

Equilibrium simulation of SARS-CoV-2 spike protein highlights its global conformational characteristics

Impact of COVID-19 on children with complex underlying medical conditions

Impact of COVID-19 on children with complex underlying medical conditions

Estimating transmission heterogeneity dynamics of SARS-CoV-2 in Massachusetts

Estimating transmission heterogeneity dynamics of SARS-CoV-2 in Massachusetts

Brain injury markers associated with dysregulated immunological responses in COVID-19

Brain injury markers associated with dysregulated immunological responses in COVID-19

Quantum mechanical characterization of SARS-CoV-2 Omicron variant interaction with human ACE2 receptor

Quantum mechanical characterization of SARS-CoV-2 Omicron variant interaction with human ACE2 receptor

Computational comparison of SARS-CoV-2 Delta and Omicron variant binding affinity with ACE2

Computational comparison of SARS-CoV-2 Delta and Omicron variant binding affinity with ACE2

Does a COVID-19 vaccine booster improve the immune response of a poor responder?

Does a COVID-19 vaccine booster improve the immune response of a poor responder?

Long COVID-19 in frontline workers found to directly impact health service delivery

Long COVID-19 in frontline workers found to directly impact health service delivery

Epigenetic clocks have potential as biomarkers of COVID-19 vaccine responses

Epigenetic clocks have potential as biomarkers of COVID-19 vaccine responses

ORF10 protein mutations alter SARS-CoV-2 pathogenicity

ORF10 protein mutations alter SARS-CoV-2 pathogenicity

The antiviral potential of 4′-fluorouridine as an oral treatment against RSV and SARS-CoV-2

The antiviral potential of 4′-fluorouridine as an oral treatment against RSV and SARS-CoV-2

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.